Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
plant inspections
Manufacturing
FDA hits Biocon's insulin copycat with a CRL
Biocon’s insulin copycat hit another roadblock as the FDA issued a complete response letter, saying its production facility must be re-inspected.
Joseph Keenan
Oct 9, 2023 11:53am
Coherus, Junshi eye FDA finish line after plant inspection
Jun 1, 2023 9:40am
FDA flags 'deficient' manufacturing standards at Global Pharma
Apr 4, 2023 8:35am
FDA cites complaint-plagued Cipla facility in scathing report
Mar 7, 2023 9:35am
Troubled Torrent plant gets FDA 'official action' letter
Jan 24, 2023 9:00am
Intas' Gujarat, India facility is in the FDA's crosshairs
Jan 20, 2023 10:17am